US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quoin Pharmaceuticals

5.77

+0.10091.78%

Volume:13.72K

Turnover:79.48K

Market Cap:3.39M

PE:-0.09

High:6.03

Open:5.85

Low:5.49

Close:5.67

Loading ...

Overview Company News Filings

Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure

Insider Buyers At Quoin Pharmaceuticals Likely Disappointed With 13% Slide

Simply Wall St.

Quoin Pharmaceuticals: Buy Rating Affirmed Amidst Potential First-Mover Advantage in Netherton Syndrome Treatment

Skinvisible Advances with Quoin Pharmaceuticals’ FDA Clearance

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome

Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies

ACCESS Newswire

Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

Buy Rating Reaffirmed for Quoin Pharmaceuticals Amid Promising QRX003 Developments and Market Potential

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Prices $6.8 Million Equity Offering -- Shares Fall

MT Newswires Live

Quoin Pharmaceuticals prices 15.1M ADSs at 45c in public offering

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

Quoin Pharmaceuticals announces FDA clearance to initiate QRX003 study

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

Quoin Pharmaceuticals files to sell 19.23M ordinary shares

Quoin Pharmaceuticals Annual Meeting Approves Key Amendments

ADRs End Higher; Quoin Pharmaceuticals Ltd. Climbs 28%

QNRX: International Sites Participating in QRX003 NS Study, Studying QRX003 for Additional Diseases, in Younger Populations

Zacks Small Cap Research

Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/QNRX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QNRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","market":"US","secType":"STK","nameCN":"Quoin Pharmaceuticals","latestPrice":5.7709,"timestamp":1745342838945,"preClose":5.67,"halted":0,"volume":13715,"delay":0,"floatShares":546540,"shares":588166,"eps":-66.90209,"marketStatus":"Trading","change":0.1009,"latestTime":"04-22 13:28:57 EDT","open":5.85,"high":6.03,"low":5.49,"amount":79482.49424049999,"amplitude":0.095238,"askPrice":5.88,"askSize":2,"bidPrice":5.73,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-66.90209,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"adrRate":35,"exchange":"NASDAQ","adjPreClose":5.67,"preHourTrading":{"tag":"盘前","latestPrice":5.67,"preClose":5.67,"latestTime":"08:58 EDT","volume":23,"amount":130.489994,"timestamp":1745326694316},"postHourTrading":{"tag":"盘后","latestPrice":5.66,"preClose":5.67,"latestTime":"18:03 EDT","volume":497,"amount":2875.61,"timestamp":1745272985780},"volumeRatio":0.400079},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNRX\",,,,,undefined,":{"symbol":"QNRX","floatShares":546540,"roa":"-42.72%","roe":"-120.55%","lyrEps":-66.902093,"volumeRatio":0.400079,"shares":588166,"dividePrice":0,"high":6.03,"amplitude":0.095238,"preClose":5.67,"low":5.49,"week52Low":5.01,"pbRate":"0.37","week52High":54.95,"institutionHeld":0,"latestPrice":5.7709,"eps":-66.90209,"divideRate":0,"volume":13715,"delay":0,"ttmEps":-66.90209,"open":5.85,"prevYearClose":22.7745,"prevWeekClose":5.4786,"prevMonthClose":7.8365,"prevQuarterClose":7.8365,"fiveDayClose":5.2799,"twentyDayClose":10.36,"sixtyDayClose":13.3315},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNRX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2508455512","title":"Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure","url":"https://stock-news.laohu8.com/highlight/detail?id=2508455512","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508455512?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:30","pubTimestamp":1738672200,"startTime":"0","endTime":"0","summary":"Multi-pronged media campaign to raise awareness about the disease and its impact on patients, family members and caregivers.Quoin’s QRX003 product is on track to obtain the first regulatory approval for Netherton Syndrome.Netherton Syndrome patients suffer from excess skin shedding as well as red, scaly skin that can cause painful itching and severe infections that can potentially lead to hospitalization, asthma, allergies and possibly skin cancer. They are also susceptible to water loss through the skin’s surface and are always at risk of dehydration. This chronic condition severely impacts every aspect of life for patients and their families, yet it remains inadequately understood and poorly addressed by current treatment options.The NETHERTON NOW website serves as a comprehensive resource hub, providing a platform for patients and families to share experiences and build connectio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quoin-pharmaceuticals-launches-netherton-now-123000008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BMPRXN33.USD","LU1064131342.USD","LU2087625088.SGD","BK4534","IE00B19Z9Z06.USD","LU1153585028.USD","LU1951198990.SGD","LU2106854487.HKD","ETH","BK4581","LU0820561818.USD","LU0320765059.SGD","BK4097","LU0708995401.HKD","LU0689472784.USD","LU1116320901.HKD","LU1989764748.USD","LU2063271972.USD","LU2125909247.SGD","BK4550","LU0672654240.SGD","LU2125909593.SGD","LU2125909916.SGD","QNRX","BK4543","LU1923622291.USD","LU0943347566.SGD","LU0348723411.USD","LU1551013425.SGD","BK4503","LU0265550359.USD","LU1267930730.SGD","BK4601","LU2023250504.SGD","GENE","LU0081259029.USD","IE00BMPRXR70.SGD","BK4588","LU2023250843.SGD","IE00B19Z9P08.USD","LU0316494557.USD","LU0354030438.USD","LU0889565833.HKD","BK4121","LU1923623000.USD","LU0109392836.USD","LU0265550946.USD","LU2458330243.SGD","LU1988902786.USD"],"gpt_icon":1},{"id":"2508136072","title":"Insider Buyers At Quoin Pharmaceuticals Likely Disappointed With 13% Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2508136072","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508136072?lang=en_us&edition=fundamental","pubTime":"2025-02-02 22:49","pubTimestamp":1738507760,"startTime":"0","endTime":"0","summary":"The recent 13% drop in Quoin Pharmaceuticals, Ltd.'s  stock could come as a blow to insiders who purchased US$580.9k worth of stock at an average buy price of US$0.48 over the past 12 months. Insiders invest with the hopes of seeing their money grow in value over time. However, as a result of recent losses, their initial investment is now only worth US$404.8k, which is not what they expected.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.Quoin Pharmaceuticals Insider Transactions Over The Last Year. Insiders At Quoin Pharmaceuticals Have Bought Stock Recently. The recent insider purchases are heartening. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-buyers-quoin-pharmaceuticals-likely-144920034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2506486033","title":"Quoin Pharmaceuticals: Buy Rating Affirmed Amidst Potential First-Mover Advantage in Netherton Syndrome Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2506486033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506486033?lang=en_us&edition=fundamental","pubTime":"2025-01-25 00:15","pubTimestamp":1737735312,"startTime":"0","endTime":"0","summary":"Analyst Naz Rahman from Maxim Group reiterated a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report) and keeping the price target at $2.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/quoin-pharmaceuticals-buy-rating-affirmed-amidst-potential-first-mover-advantage-in-netherton-syndrome-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/quoin-pharmaceuticals-buy-rating-affirmed-amidst-potential-first-mover-advantage-in-netherton-syndrome-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"gpt_icon":0},{"id":"2505026867","title":"Skinvisible Advances with Quoin Pharmaceuticals’ FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2505026867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505026867?lang=en_us&edition=fundamental","pubTime":"2025-01-24 04:52","pubTimestamp":1737665525,"startTime":"0","endTime":"0","summary":"Skinvisible ( ($SKVI) ) has issued an update. Skinvisible announced significant achievements in 2024 and 2025 through its licensee, Quoin Pharmaceu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/skinvisible-advances-with-quoin-pharmaceuticals-fda-clearance?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/skinvisible-advances-with-quoin-pharmaceuticals-fda-clearance?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2505134100","title":"Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2505134100","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505134100?lang=en_us&edition=fundamental","pubTime":"2025-01-23 21:30","pubTimestamp":1737639000,"startTime":"0","endTime":"0","summary":"Four Weeks After Discontinuation of Treatment with QRX003 Complete Reversal of Positive Clinical Improvements Across all Measured Endpoints ObservedData Supports QRX003 Mechanism of Action as a Compet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/23/3014276/0/en/Quoin-Pharmaceuticals-Announces-Further-Clinical-Evidence-of-QRX003-Effectiveness-in-Netherton-Syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2505095684","title":"Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2505095684","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505095684?lang=en_us&edition=fundamental","pubTime":"2025-01-23 18:30","pubTimestamp":1737628200,"startTime":"0","endTime":"0","summary":"LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. , , an innovative topical and transdermal pharmaceutical research and development company, with proprietary Invisicare drug delivery technology, today announces significant achievements in 2024 and 2025, through its licensee Quoin Pharmaceuticals' progress in Netherton Syndrome treatment.Skinvisible granted Quoin an exclusive, royalty-bearing license to its technology for use in select rare skin diseases and for the right to use its proprietary formula for Netherton Syndrome. Netherton Syndrome is a hereditary disorder affecting the skin, hair, and immune system, currently lacking an approved treatment or cure. Quoin is responsible for obtaining all FDA and other regulatory body approvals necessary to market the products in the US and other countries. Upon the successful completion of FDA or EU approval, Skinvisible is entitled to receive a milestone payment of $5 million and ongoing royalties from s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/skinvisible-reports-licensee-success-netherton-103000058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","QNRX","SKVI","BK4183"],"gpt_icon":0},{"id":"2503578720","title":"Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578720","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578720?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"Continued Significant Improvement in Skin Appearance Observed in StudySubject’s Disease Classification Improved from “Severe” to “Mild” after 6 Weeks Dosing Treatment area expanded from 20% Body Surfa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/14/3009328/0/en/Quoin-Pharmaceuticals-Announces-Further-Positive-Clinical-Data-from-Ongoing-Pediatric-Netherton-Syndrome-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IGA","QNRX","BK4139","BSA"],"gpt_icon":0},{"id":"2501731161","title":"PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2501731161","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501731161?lang=en_us&edition=fundamental","pubTime":"2025-01-08 03:29","pubTimestamp":1736278140,"startTime":"0","endTime":"0","summary":"Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003. NEW YORK, Jan. 07, 2025  -- PRISM MarketViewhas released an exclusive interview with Quoin Pharmaceuticals Ltd.  CEO Dr. Michael Myers, who shares the company’s notable interim data in its ongoing Netherton Syndrome clinical trials. Quoin, a clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, is addressing unmet medical needs for those with Netherton Syndrome , a rare and sometimes fatal skin disease for which there is currently no approved treatment and no cure.Dr. Myers concluded, “Looking ahead, Quoin is committed to ensuring that every patient, no matter where they are in the world, will have access to our product once approved. This commitment drives our efforts to advance QRX003 as the first FDA-approved treatment for Netherton Syndrome, meeting the needs of this underserved community.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/prism-marketview-spotlights-quoin-pharmaceuticals-192900898.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4157","IE00B7SZL793.SGD","IE0031619046.USD","MYE","AEIS","BK4126","QNRX"],"gpt_icon":0},{"id":"2501355557","title":"Buy Rating Reaffirmed for Quoin Pharmaceuticals Amid Promising QRX003 Developments and Market Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2501355557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501355557?lang=en_us&edition=fundamental","pubTime":"2025-01-08 02:15","pubTimestamp":1736273715,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Naz Rahman from Maxim Group reiterated a Buy rating on Quoin Pharmaceuticals (QNRX – Research Report), with a price...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/buy-rating-reaffirmed-for-quoin-pharmaceuticals-amid-promising-qrx003-developments-and-market-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/buy-rating-reaffirmed-for-quoin-pharmaceuticals-amid-promising-qrx003-developments-and-market-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX"],"gpt_icon":0},{"id":"2501234478","title":"Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2501234478","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501234478?lang=en_us&edition=fundamental","pubTime":"2025-01-06 21:30","pubTimestamp":1736170200,"startTime":"0","endTime":"0","summary":"Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label StudyDemonstrated Clinical Benefits from QRX003 Observed Across All Measured Endpoi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/06/3004620/0/en/Quoin-Pharmaceuticals-Announces-Additional-Positive-Interim-Data-from-Ongoing-Open-Label-Netherton-Syndrome-Clinical-Study.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2493423416","title":"Quoin Pharmaceuticals Prices $6.8 Million Equity Offering -- Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2493423416","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493423416?lang=en_us&edition=fundamental","pubTime":"2024-12-21 00:17","pubTimestamp":1734711425,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals  said Friday it has priced a public offering of 15.1 million American Depositary Shares, along with Series F and Series G warrants to purchase an equal number of ADSs, at $0.45 per ADS for a total of $6.8 million in gross proceeds.One ADS represents one ordinary share of the company.The funds will be used for general corporate purposes, including research and development, Quoin Pharmaceuticals said.The offering is expected to close by Monday.Quoin Pharmaceuticals shares fell nearly 6% in recent trading.Price: 0.61, Change: -0.04, Percent Change: -5.69","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4215","BK4588","BK4585","QNRX","EQR"],"gpt_icon":0},{"id":"2492445374","title":"Quoin Pharmaceuticals prices 15.1M ADSs at 45c in public offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2492445374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492445374?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:30","pubTimestamp":1734705036,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announced the pricing of its “reasonable best efforts” public offering of 15,111,110 ordinary shares represented by 15...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-prices-15-1m-adss-at-45c-in-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-prices-15-1m-adss-at-45c-in-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2492244185","title":"Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2492244185","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492244185?lang=en_us&edition=fundamental","pubTime":"2024-12-20 22:20","pubTimestamp":1734704400,"startTime":"0","endTime":"0","summary":"ASHBURN, Va., Dec.  20, 2024  (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan di","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/20/3000658/0/en/Quoin-Pharmaceuticals-Announces-Pricing-of-6-8-Million-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2492120515","title":"Quoin Pharmaceuticals announces FDA clearance to initiate QRX003 study","url":"https://stock-news.laohu8.com/highlight/detail?id=2492120515","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492120515?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:11","pubTimestamp":1734613864,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals (QNRX) announces FDA clearance to initiate a new additional Netherton Syndrome clinical study for QRX003. QRX003 is a topical...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-announces-fda-clearance-to-initiate-qrx003-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-announces-fda-clearance-to-initiate-qrx003-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2492183264","title":"Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2492183264","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492183264?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:18","pubTimestamp":1734527880,"startTime":"0","endTime":"0","summary":"Clinical Data from First Subject Dosed Twice Daily with QRX003 in Open Label Study Is Positive at Mid-point of TestingSignificant Improvement in Skin Appearance Observed in Pediatric Study after Only ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/18/2999032/0/en/Quoin-Pharmaceuticals-Announces-Positive-Interim-Data-from-Two-Ongoing-Netherton-Syndrome-Clinical-Studies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IGA","QNRX"],"gpt_icon":1},{"id":"2490813222","title":"Quoin Pharmaceuticals files to sell 19.23M ordinary shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2490813222","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490813222?lang=en_us&edition=fundamental","pubTime":"2024-12-12 05:25","pubTimestamp":1733952326,"startTime":"0","endTime":"0","summary":"Maxim Group is acting as the exclusive placement agent for this offering. Published first on TheFly – the ultimate source for real-time, market-mov...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-files-to-sell-19-23m-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quoin-pharmaceuticals-files-to-sell-19-23m-ordinary-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QNRX"],"gpt_icon":0},{"id":"2490902270","title":"Quoin Pharmaceuticals Annual Meeting Approves Key Amendments","url":"https://stock-news.laohu8.com/highlight/detail?id=2490902270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490902270?lang=en_us&edition=fundamental","pubTime":"2024-12-11 06:00","pubTimestamp":1733868039,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals ( ($QNRX) ) has shared an update. Quoin Pharmaceuticals Ltd. held its 2024 Annual General Meeting where shareholders approved...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-annual-meeting-approves-key-amendments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-annual-meeting-approves-key-amendments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2488971330","title":"ADRs End Higher; Quoin Pharmaceuticals Ltd. Climbs 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488971330","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488971330?lang=en_us&edition=fundamental","pubTime":"2024-12-04 05:31","pubTimestamp":1733261460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Tuesday, as the S&P/BNY Mellon index of American depositary receipts added 0.8% to 184.06.The European index increased 0.6% to 168.77. The Asian index rose 1.1% to 236.87. The Latin American index increased 0.6% to 184.91, while the emerging-markets index added 1.1% to 382.50.Israel's Quoin Pharmaceuticals Ltd. was the biggest leader during the session, soaring 28% to 82 cents, and China-based Uxin Ltd. rocketed 21% to $5.11. 36Kr Holdings Inc., which is based in China, rounded out the top three leaders on Tuesday, with shares surging 18% to $3.91.Purple Biotech Ltd., based in Israel, posted the largest decline, plummeting 22% to $6.57, followed by shares of Hong Kong's iClick Interactive Asia Group Ltd., which plunged 19% to $4.80. Shares of Japan-based Lead Real Estate Co. Ltd. plunged 18% to $1.93.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNRX","BK4139"],"gpt_icon":0},{"id":"2483397830","title":"QNRX: International Sites Participating in QRX003 NS Study, Studying QRX003 for Additional Diseases, in Younger Populations","url":"https://stock-news.laohu8.com/highlight/detail?id=2483397830","media":"Zacks Small Cap Research","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483397830?lang=en_us&edition=fundamental","pubTime":"2024-11-12 19:00","pubTimestamp":1731409200,"startTime":"0","endTime":"0","summary":"U.S. and International Sites participating in QRX003 NS study, Expanding to study QRX003 for additional indications and in younger patient populations. Quoin Pharmaceuticals  provided a business update last week. The company implemented a number of measures during the quarter to move lead asset QRX003 forward. For instance, Quoin initiated testing of the safety and efficacy of QRX003 in a pediatric patient with Netherton Syndrome . NS is a rare inherited genetic disease for which there is currently no approved treatment or cure. This initiative addresses multiple QNRX’s objectives, including studying QRX003 in pediatric patient populations. Treating pediatric patients is important, as early treatment is critical to managing the disease. The company also commenced measures to expand clinical activities on QRX003 internationally. Separately, management raised its stake in QNRX shares, which we view as a positive indicator of its optimism about the company’s prospects.Two active late stag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/qnrx-international-sites-participating-qrx003-110000612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NS","NORD","BK4139","BK4590","QNRX","BK4144"],"gpt_icon":1},{"id":"2482413648","title":"Quoin Pharmaceuticals at Risk of Nasdaq Delisting Amidst Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2482413648","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482413648?lang=en_us&edition=fundamental","pubTime":"2024-11-09 14:01","pubTimestamp":1731132064,"startTime":"0","endTime":"0","summary":"Quoin Pharmaceuticals Ltd (QNRX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Quoin Pharmaceuticals Ltd faces a sign...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-at-risk-of-nasdaq-delisting-amidst-financial-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/quoin-pharmaceuticals-at-risk-of-nasdaq-delisting-amidst-financial-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QLD","NQmain","BK4139","QID","MNQmain","LU2210149790.SGD","BK4112","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4588","PSQ","IE00BKPKM429.USD","NDAQ",".IXIC","SQQQ","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","QNRX","TQQQ"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-04-09","symbol":"QNRX","defaultRemindTime":1744205400000,"type":"split","dateTimestamp":1744171200000,"forFactor":35,"toFactor":1,"ratio":35},{"market":"US","date":"2025-03-13","symbol":"QNRX","fiscalQuarterEnding":"2024/12","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"pre","actualEps":-0.35},{"market":"US","date":"2024-11-07","symbol":"QNRX","fiscalQuarterEnding":"2024/09","expectedEps":-0.44,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.47},{"market":"US","date":"2024-08-08","symbol":"QNRX","fiscalQuarterEnding":"2024/06","expectedEps":-0.75,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2024-05-09","symbol":"QNRX","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-1.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1718424000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNRX","date":"2025-04-21","current":-0.359535,"percent":0.702254,"low":-17.346367,"twenty":-0.738173,"median":-0.460563,"eighty":-0.309633,"high":-0.000007,"avg":-0.813906,"sd":1.721332,"marketCap":3222326},"quantilePoints":[{"date":"2021-10-29","current":-17.346367,"twenty":-17.346367,"median":-17.346367,"eighty":-17.346367,"marketCap":97148313},{"date":"2021-11-05","current":-12.667021,"twenty":-16.958905,"median":-15.73691,"eighty":-14.60433,"marketCap":70941637},{"date":"2021-11-12","current":-8.658281,"twenty":-16.765174,"median":-12.667021,"eighty":-10.28264,"marketCap":48490695},{"date":"2021-11-19","current":-7.615115,"twenty":-14.708646,"median":-10.506176,"eighty":-8.241015,"marketCap":42648443},{"date":"2021-11-26","current":-3.943296,"twenty":-14.625193,"median":-8.598672,"eighty":-7.442247,"marketCap":37807719},{"date":"2021-12-03","current":-2.811666,"twenty":-13.054483,"median":-8.241015,"eighty":-3.931109,"marketCap":26957822},{"date":"2021-12-10","current":-3.055402,"twenty":-11.760956,"median":-7.592761,"eighty":-3.245167,"marketCap":29294723},{"date":"2021-12-17","current":-1.862838,"twenty":-10.890658,"median":-4.02164,"eighty":-3.025805,"marketCap":17860600},{"date":"2021-12-23","current":-1.549649,"twenty":-10.461469,"median":-3.943296,"eighty":-2.794256,"marketCap":16525228},{"date":"2021-12-31","current":-1.424425,"twenty":-9.308025,"median":-3.294786,"eighty":-1.787652,"marketCap":15189856},{"date":"2022-01-07","current":-1.627915,"twenty":-8.58675,"median":-3.203384,"eighty":-1.577825,"marketCap":17359836},{"date":"2022-01-14","current":-1.267895,"twenty":-8.485414,"median":-3.107631,"eighty":-1.488603,"marketCap":13520641},{"date":"2022-01-21","current":-1.0331,"twenty":-8.366195,"median":-2.876952,"eighty":-1.447905,"marketCap":11016819},{"date":"2022-01-28","current":-0.970488,"twenty":-8.163523,"median":-2.768142,"eighty":-1.377466,"marketCap":10349133},{"date":"2022-02-04","current":-1.111365,"twenty":-7.874416,"median":-1.976001,"eighty":-1.235023,"marketCap":11851426},{"date":"2022-02-11","current":-1.085306,"twenty":-7.597232,"median":-1.674874,"eighty":-1.127775,"marketCap":11573542},{"date":"2022-02-18","current":-1.061713,"twenty":-7.314087,"median":-1.573129,"eighty":-1.113525,"marketCap":11321943},{"date":"2022-02-25","current":-0.865099,"twenty":-6.348012,"median":-1.498777,"eighty":-1.105103,"marketCap":9225287},{"date":"2022-03-04","current":-0.904422,"twenty":-4.019899,"median":-1.479211,"eighty":-1.071673,"marketCap":9644618},{"date":"2022-03-11","current":-1.163952,"twenty":-3.999007,"median":-1.447905,"eighty":-1.061713,"marketCap":12412205},{"date":"2022-03-18","current":-1.163952,"twenty":-3.931109,"median":-1.416599,"eighty":-1.037796,"marketCap":12412205},{"date":"2022-03-25","current":-1.148223,"twenty":-3.765718,"median":-1.381379,"eighty":-1.057606,"marketCap":12244472},{"date":"2022-04-01","current":-1.053848,"twenty":-3.297397,"median":-1.299201,"eighty":-1.053848,"marketCap":11238077},{"date":"2022-04-08","current":-0.928015,"twenty":-3.283469,"median":-1.222936,"eighty":-1.035677,"marketCap":9896217},{"date":"2022-04-14","current":-0.476722,"twenty":-3.255613,"median":-1.205283,"eighty":-1.00962,"marketCap":10231682},{"date":"2022-04-22","current":-0.410293,"twenty":-3.203384,"median":-1.163952,"eighty":-0.975203,"marketCap":8805956},{"date":"2022-04-29","current":-0.313073,"twenty":-3.185975,"median":-1.153274,"eighty":-0.954835,"marketCap":6719363},{"date":"2022-05-06","current":-0.308697,"twenty":-3.15986,"median":-1.132494,"eighty":-0.920151,"marketCap":6625433},{"date":"2022-05-13","current":-0.243519,"twenty":-3.055402,"median":-1.120697,"eighty":-0.880828,"marketCap":5226544},{"date":"2022-05-20","current":-0.246137,"twenty":-2.907419,"median":-1.111365,"eighty":-0.857235,"marketCap":5282735},{"date":"2022-05-27","current":-0.275987,"twenty":-2.846486,"median":-1.107451,"eighty":-0.468907,"marketCap":5310410},{"date":"2022-06-03","current":-0.26812,"twenty":-2.81863,"median":-1.087972,"eighty":-0.44468,"marketCap":5159040},{"date":"2022-06-10","current":-0.203983,"twenty":-2.776847,"median":-1.085306,"eighty":-0.385285,"marketCap":3924940},{"date":"2022-06-17","current":-0.152291,"twenty":-2.489587,"median":-1.07351,"eighty":-0.319364,"marketCap":2930308},{"date":"2022-06-24","current":-0.155212,"twenty":-2.221478,"median":-1.061713,"eighty":-0.298542,"marketCap":2986515},{"date":"2022-07-01","current":-0.267305,"twenty":-1.953368,"median":-1.056579,"eighty":-0.277405,"marketCap":5143349},{"date":"2022-07-08","current":-0.231074,"twenty":-1.787652,"median":-1.053848,"eighty":-0.273302,"marketCap":4446216},{"date":"2022-07-15","current":-0.178755,"twenty":-1.674874,"median":-1.039542,"eighty":-0.267462,"marketCap":3439525},{"date":"2022-07-22","current":-0.183115,"twenty":-1.65609,"median":-1.030254,"eighty":-0.25072,"marketCap":3523416},{"date":"2022-07-29","current":-0.155517,"twenty":-1.615393,"median":-0.994864,"eighty":-0.244988,"marketCap":2992387},{"date":"2022-08-05","current":-1.0024,"twenty":-1.577825,"median":-0.983067,"eighty":-0.2438,"marketCap":19287705},{"date":"2022-08-12","current":-0.905761,"twenty":-1.530865,"median":-0.979135,"eighty":-0.244988,"marketCap":17428209},{"date":"2022-08-19","current":-1.261787,"twenty":-1.49956,"median":-0.983067,"eighty":-0.24634,"marketCap":22172308},{"date":"2022-08-26","current":-1.00506,"twenty":-1.494864,"median":-1.00373,"eighty":-0.247189,"marketCap":17661059},{"date":"2022-09-02","current":-0.83846,"twenty":-1.488603,"median":-0.983067,"eighty":-0.248209,"marketCap":14733547},{"date":"2022-09-09","current":-1.015985,"twenty":-1.47295,"median":-0.985942,"eighty":-0.249617,"marketCap":17853027},{"date":"2022-09-16","current":-0.999598,"twenty":-1.447905,"median":-1.000999,"eighty":-0.2541,"marketCap":17565075},{"date":"2022-09-23","current":-0.80537,"twenty":-1.447905,"median":-0.994135,"eighty":-0.255867,"marketCap":14152083},{"date":"2022-09-30","current":-0.61506,"twenty":-1.446166,"median":-0.983139,"eighty":-0.262906,"marketCap":10807926},{"date":"2022-10-07","current":-0.604028,"twenty":-1.436253,"median":-0.98189,"eighty":-0.267383,"marketCap":10614062},{"date":"2022-10-14","current":-0.471638,"twenty":-1.42286,"median":-0.968913,"eighty":-0.267782,"marketCap":8287692},{"date":"2022-10-21","current":-0.562656,"twenty":-1.413468,"median":-0.966397,"eighty":-0.2688,"marketCap":9887072},{"date":"2022-10-28","current":-0.529559,"twenty":-1.393119,"median":-0.950476,"eighty":-0.271699,"marketCap":9305479},{"date":"2022-11-04","current":-0.485429,"twenty":-1.358698,"median":-0.943659,"eighty":-0.272858,"marketCap":8530023},{"date":"2022-11-11","current":-0.479672,"twenty":-1.345188,"median":-0.923004,"eighty":-0.274906,"marketCap":9208547},{"date":"2022-11-18","current":-0.459476,"twenty":-1.332632,"median":-0.91334,"eighty":-0.276144,"marketCap":8820819},{"date":"2022-11-25","current":-0.462,"twenty":-1.299201,"median":-0.906739,"eighty":-0.276772,"marketCap":8869285},{"date":"2022-12-02","current":-0.441804,"twenty":-1.267895,"median":-0.903164,"eighty":-0.277827,"marketCap":8481557},{"date":"2022-12-09","current":-0.393836,"twenty":-1.261787,"median":-0.893083,"eighty":-0.277839,"marketCap":7560702},{"date":"2022-12-16","current":-0.386263,"twenty":-1.226868,"median":-0.869031,"eighty":-0.278907,"marketCap":7415304},{"date":"2022-12-23","current":-0.333246,"twenty":-1.219003,"median":-0.857235,"eighty":-0.28331,"marketCap":6397517},{"date":"2022-12-30","current":-0.358492,"twenty":-1.214288,"median":-0.83846,"eighty":-0.285895,"marketCap":6882177},{"date":"2023-01-06","current":-0.366066,"twenty":-1.203717,"median":-0.830267,"eighty":-0.294872,"marketCap":7027575},{"date":"2023-01-13","current":-0.419082,"twenty":-1.196726,"median":-0.751587,"eighty":-0.305389,"marketCap":8045362},{"date":"2023-01-20","current":-0.388787,"twenty":-1.192762,"median":-0.704699,"eighty":-0.310447,"marketCap":7463770},{"date":"2023-01-27","current":-0.393836,"twenty":-1.178108,"median":-0.684013,"eighty":-0.314277,"marketCap":7560702},{"date":"2023-02-03","current":-0.59078,"twenty":-1.163952,"median":-0.661949,"eighty":-0.317723,"marketCap":11341538},{"date":"2023-02-10","current":-0.421607,"twenty":-1.163758,"median":-0.631609,"eighty":-0.320717,"marketCap":8093828},{"date":"2023-02-17","current":-0.353443,"twenty":-1.161409,"median":-0.60749,"eighty":-0.323804,"marketCap":6785245},{"date":"2023-02-24","current":-0.118656,"twenty":-1.156304,"median":-0.591888,"eighty":-0.313675,"marketCap":2277903},{"date":"2023-03-03","current":-0.281484,"twenty":-1.14665,"median":-0.562656,"eighty":-0.29262,"marketCap":5403806},{"date":"2023-03-10","current":-0.522124,"twenty":-1.138785,"median":-0.550992,"eighty":-0.287367,"marketCap":4898302},{"date":"2023-03-17","current":-0.593625,"twenty":-1.130921,"median":-0.551624,"eighty":-0.29122,"marketCap":5569088},{"date":"2023-03-24","current":-0.65651,"twenty":-1.124629,"median":-0.575443,"eighty":-0.294825,"marketCap":6159049},{"date":"2023-03-31","current":-0.60057,"twenty":-1.123056,"median":-0.592995,"eighty":-0.300426,"marketCap":5634244},{"date":"2023-04-06","current":-0.603601,"twenty":-1.116764,"median":-0.60057,"eighty":-0.300426,"marketCap":5662676},{"date":"2023-04-14","current":-0.560679,"twenty":-1.116764,"median":-0.592742,"eighty":-0.308697,"marketCap":5260010},{"date":"2023-04-21","current":-0.580997,"twenty":-1.111365,"median":-0.593625,"eighty":-0.313073,"marketCap":5450622},{"date":"2023-04-28","current":-0.649313,"twenty":-1.111365,"median":-0.598171,"eighty":-0.316082,"marketCap":6091523},{"date":"2023-05-05","current":-0.60259,"twenty":-1.111365,"median":-0.60259,"eighty":-0.320185,"marketCap":5653199},{"date":"2023-05-12","current":-0.55198,"twenty":-1.103538,"median":-0.60158,"eighty":-0.321514,"marketCap":5686369},{"date":"2023-05-19","current":-0.55198,"twenty":-1.10065,"median":-0.595771,"eighty":-0.327238,"marketCap":5686369},{"date":"2023-05-26","current":-0.505982,"twenty":-1.088059,"median":-0.592742,"eighty":-0.333246,"marketCap":5212505},{"date":"2023-06-02","current":-0.499658,"twenty":-1.08792,"median":-0.589505,"eighty":-0.344867,"marketCap":5147361},{"date":"2023-06-09","current":-0.55704,"twenty":-1.087172,"median":-0.580997,"eighty":-0.350289,"marketCap":5738494},{"date":"2023-06-16","current":-0.620978,"twenty":-1.085644,"median":-0.584704,"eighty":-0.352938,"marketCap":6397166},{"date":"2023-06-23","current":-0.676176,"twenty":-1.085306,"median":-0.589505,"eighty":-0.356472,"marketCap":6965803},{"date":"2023-06-30","current":-0.593264,"twenty":-1.083207,"median":-0.591634,"eighty":-0.359502,"marketCap":6111663},{"date":"2023-07-07","current":-0.517481,"twenty":-1.079536,"median":-0.587708,"eighty":-0.361522,"marketCap":5330971},{"date":"2023-07-14","current":-0.54646,"twenty":-1.077168,"median":-0.582224,"eighty":-0.364046,"marketCap":5629506},{"date":"2023-07-21","current":-0.623853,"twenty":-1.07607,"median":-0.587708,"eighty":-0.366571,"marketCap":6426782},{"date":"2023-07-28","current":-0.721599,"twenty":-1.07607,"median":-0.591634,"eighty":-0.36859,"marketCap":7433744},{"date":"2023-08-04","current":-0.757094,"twenty":-1.073339,"median":-0.593264,"eighty":-0.36859,"marketCap":7374510},{"date":"2023-08-11","current":-0.62027,"twenty":-1.070607,"median":-0.595859,"eighty":-0.371115,"marketCap":6041768},{"date":"2023-08-18","current":-0.543243,"twenty":-1.069577,"median":-0.593625,"eighty":-0.376164,"marketCap":5291483},{"date":"2023-08-25","current":-0.538176,"twenty":-1.067876,"median":-0.592742,"eighty":-0.378689,"marketCap":5242122},{"date":"2023-09-01","current":-0.58277,"twenty":-1.065691,"median":-0.589505,"eighty":-0.378689,"marketCap":5676497},{"date":"2023-09-08","current":-0.590878,"twenty":-1.063086,"median":-0.590829,"eighty":-0.378689,"marketCap":5755475},{"date":"2023-09-15","current":-0.569594,"twenty":-1.061713,"median":-0.58823,"eighty":-0.378689,"marketCap":5548159},{"date":"2023-09-22","current":-0.506757,"twenty":-1.061713,"median":-0.585904,"eighty":-0.378689,"marketCap":4936085},{"date":"2023-09-29","current":-0.433865,"twenty":-1.060727,"median":-0.581611,"eighty":-0.380709,"marketCap":4226078},{"date":"2023-10-06","current":-0.427703,"twenty":-1.05818,"median":-0.578696,"eighty":-0.383738,"marketCap":4166055},{"date":"2023-10-13","current":-0.408953,"twenty":-1.055487,"median":-0.574156,"eighty":-0.383738,"marketCap":3983420},{"date":"2023-10-20","current":-0.41554,"twenty":-1.053848,"median":-0.568243,"eighty":-0.383738,"marketCap":4047589},{"date":"2023-10-27","current":-0.435811,"twenty":-1.053848,"median":-0.56578,"eighty":-0.383738,"marketCap":4245033},{"date":"2023-11-03","current":-0.435811,"twenty":-1.053848,"median":-0.56554,"eighty":-0.384243,"marketCap":4245033},{"date":"2023-11-10","current":-0.411508,"twenty":-1.050251,"median":-0.562656,"eighty":-0.384243,"marketCap":4008308},{"date":"2023-11-17","current":-0.498316,"twenty":-1.046658,"median":-0.560987,"eighty":-0.385884,"marketCap":4304279},{"date":"2023-11-24","current":-0.522671,"twenty":-1.041435,"median":-0.560318,"eighty":-0.386263,"marketCap":4514655},{"date":"2023-12-01","current":-0.568388,"twenty":-1.035221,"median":-0.558953,"eighty":-0.387777,"marketCap":4909543},{"date":"2023-12-08","current":-0.568034,"twenty":-1.0331,"median":-0.560318,"eighty":-0.388787,"marketCap":4906483},{"date":"2023-12-15","current":-0.484601,"twenty":-1.031392,"median":-0.558953,"eighty":-0.389637,"marketCap":4185812},{"date":"2023-12-22","current":-0.477732,"twenty":-1.021693,"median":-0.557743,"eighty":-0.390868,"marketCap":4126480},{"date":"2023-12-29","current":-0.588241,"twenty":-1.014712,"median":-0.55704,"eighty":-0.391312,"marketCap":5081023},{"date":"2024-01-05","current":-0.532603,"twenty":-1.010893,"median":-0.55589,"eighty":-0.391312,"marketCap":4600445},{"date":"2024-01-12","current":-0.526889,"twenty":-1.007253,"median":-0.553378,"eighty":-0.393331,"marketCap":4551084},{"date":"2024-01-19","current":-0.454873,"twenty":-1.0057,"median":-0.55198,"eighty":-0.393836,"marketCap":3929036},{"date":"2024-01-26","current":-0.427454,"twenty":-1.003464,"median":-0.551802,"eighty":-0.393836,"marketCap":3692202},{"date":"2024-02-02","current":-0.394309,"twenty":-1.000719,"median":-0.549335,"eighty":-0.39412,"marketCap":3405909},{"date":"2024-02-09","current":-0.38288,"twenty":-0.99632,"median":-0.548588,"eighty":-0.392826,"marketCap":3307187},{"date":"2024-02-16","current":-0.318876,"twenty":-0.989219,"median":-0.547495,"eighty":-0.388787,"marketCap":2754343},{"date":"2024-02-23","current":-0.301732,"twenty":-0.98485,"median":-0.546977,"eighty":-0.385127,"marketCap":2606260},{"date":"2024-03-01","current":-0.314316,"twenty":-0.983153,"median":-0.545642,"eighty":-0.383738,"marketCap":2714953},{"date":"2024-03-08","current":-0.135997,"twenty":-0.983067,"median":-0.543349,"eighty":-0.379908,"marketCap":1174693},{"date":"2024-03-15","current":-0.20704,"twenty":-0.982596,"median":-0.542611,"eighty":-0.378689,"marketCap":1798470},{"date":"2024-03-22","current":-0.381897,"twenty":-0.979215,"median":-0.541631,"eighty":-0.378689,"marketCap":3317373},{"date":"2024-03-28","current":-0.369167,"twenty":-0.97426,"median":-0.540481,"eighty":-0.37767,"marketCap":3206793},{"date":"2024-04-05","current":-0.364923,"twenty":-0.969858,"median":-0.539696,"eighty":-0.377263,"marketCap":3169934},{"date":"2024-04-12","current":-0.326734,"twenty":-0.967338,"median":-0.538176,"eighty":-0.369557,"marketCap":2838196},{"date":"2024-04-19","current":-0.305517,"twenty":-0.96715,"median":-0.536661,"eighty":-0.365152,"marketCap":2653898},{"date":"2024-04-26","current":-0.267328,"twenty":-0.964085,"median":-0.533552,"eighty":-0.358997,"marketCap":2322161},{"date":"2024-05-03","current":-0.309761,"twenty":-0.95419,"median":-0.531461,"eighty":-0.351423,"marketCap":2690758},{"date":"2024-05-10","current":-0.337342,"twenty":-0.951156,"median":-0.528981,"eighty":-0.340821,"marketCap":2930346},{"date":"2024-05-17","current":-0.367202,"twenty":-0.948223,"median":-0.527946,"eighty":-0.340821,"marketCap":3088456},{"date":"2024-05-24","current":-0.34075,"twenty":-0.943728,"median":-0.525421,"eighty":-0.340947,"marketCap":2865976},{"date":"2024-05-31","current":-0.331712,"twenty":-0.943659,"median":-0.525,"eighty":-0.340592,"marketCap":2789958},{"date":"2024-06-07","current":-0.346334,"twenty":-0.928015,"median":-0.523469,"eighty":-0.340703,"marketCap":2912940},{"date":"2024-06-14","current":-0.340703,"twenty":-0.926289,"median":-0.522398,"eighty":-0.340681,"marketCap":2865578},{"date":"2024-06-21","current":-0.295228,"twenty":-0.922433,"median":-0.519905,"eighty":-0.336816,"marketCap":2483103},{"date":"2024-06-28","current":-0.279187,"twenty":-0.920151,"median":-0.518004,"eighty":-0.336018,"marketCap":2348182},{"date":"2024-07-05","current":-0.274313,"twenty":-0.920151,"median":-0.512285,"eighty":-0.333064,"marketCap":2307188},{"date":"2024-07-12","current":-0.307579,"twenty":-0.914702,"median":-0.509745,"eighty":-0.331195,"marketCap":2586980},{"date":"2024-07-15","current":-0.310418,"twenty":-0.91334,"median":-0.508665,"eighty":-0.331019,"marketCap":2610860},{"date":"2024-08-02","current":-0.272562,"twenty":-0.913129,"median":-0.507585,"eighty":-0.329729,"marketCap":2292462},{"date":"2024-08-09","current":-0.248051,"twenty":-0.911177,"median":-0.505359,"eighty":-0.325114,"marketCap":2086300},{"date":"2024-08-16","current":-0.24035,"twenty":-0.906543,"median":-0.501744,"eighty":-0.319687,"marketCap":1989587},{"date":"2024-08-23","current":-0.293286,"twenty":-0.905493,"median":-0.497744,"eighty":-0.316091,"marketCap":2427781},{"date":"2024-08-30","current":-0.286555,"twenty":-0.903919,"median":-0.49203,"eighty":-0.313322,"marketCap":2372062},{"date":"2024-09-06","current":-0.383339,"twenty":-0.901905,"median":-0.490945,"eighty":-0.313073,"marketCap":3173230},{"date":"2024-09-13","current":-0.311556,"twenty":-0.894391,"median":-0.486542,"eighty":-0.313073,"marketCap":2579020},{"date":"2024-09-20","current":-0.276506,"twenty":-0.893083,"median":-0.485429,"eighty":-0.309761,"marketCap":2288880},{"date":"2024-09-27","current":-0.252418,"twenty":-0.880828,"median":-0.484661,"eighty":-0.307436,"marketCap":2089484},{"date":"2024-10-04","current":-0.23434,"twenty":-0.872964,"median":-0.484601,"eighty":-0.302929,"marketCap":1939837},{"date":"2024-10-11","current":-0.252827,"twenty":-0.865099,"median":-0.482434,"eighty":-0.301027,"marketCap":2092867},{"date":"2024-10-18","current":-0.317326,"twenty":-0.857235,"median":-0.47841,"eighty":-0.300426,"marketCap":2626780},{"date":"2024-10-25","current":-0.39995,"twenty":-0.857235,"median":-0.476537,"eighty":-0.300426,"marketCap":3310734},{"date":"2024-10-31","current":-0.494182,"twenty":-0.850943,"median":-0.478071,"eighty":-0.300907,"marketCap":4090778},{"date":"2024-11-08","current":-0.422626,"twenty":-0.840642,"median":-0.476351,"eighty":-0.301191,"marketCap":3498446},{"date":"2024-11-15","current":-0.352287,"twenty":-0.834605,"median":-0.468894,"eighty":-0.301334,"marketCap":3065275},{"date":"2024-11-22","current":-0.359821,"twenty":-0.830942,"median":-0.464302,"eighty":-0.301657,"marketCap":3130826},{"date":"2024-11-29","current":-0.348213,"twenty":-0.815329,"median":-0.462,"eighty":-0.30245,"marketCap":3029832},{"date":"2024-12-06","current":-0.435267,"twenty":-0.804556,"median":-0.461782,"eighty":-0.30359,"marketCap":3787290},{"date":"2024-12-13","current":-0.420758,"twenty":-0.775862,"median":-0.460599,"eighty":-0.304922,"marketCap":3661047},{"date":"2024-12-20","current":-0.375374,"twenty":-0.755346,"median":-0.458782,"eighty":-0.305517,"marketCap":3266158},{"date":"2024-12-27","current":-0.324419,"twenty":-0.754181,"median":-0.457684,"eighty":-0.304625,"marketCap":2822793},{"date":"2025-01-03","current":-0.389709,"twenty":-0.753938,"median":-0.457139,"eighty":-0.305517,"marketCap":3390886},{"date":"2025-01-10","current":-0.36162,"twenty":-0.752966,"median":-0.455912,"eighty":-0.305517,"marketCap":3146480},{"date":"2025-01-17","current":-0.342177,"twenty":-0.750208,"median":-0.452331,"eighty":-0.307436,"marketCap":2977309},{"date":"2025-01-24","current":-0.238758,"twenty":-0.74342,"median":-0.451013,"eighty":-0.307052,"marketCap":2077454},{"date":"2025-01-31","current":-0.167665,"twenty":-0.737124,"median":-0.449377,"eighty":-0.30269,"marketCap":1458864},{"date":"2025-02-07","current":-0.757086,"twenty":-0.737124,"median":-0.448569,"eighty":-0.301334,"marketCap":6587465},{"date":"2025-02-14","current":-0.783111,"twenty":-0.74342,"median":-0.449855,"eighty":-0.301657,"marketCap":6813909},{"date":"2025-02-21","current":-0.78737,"twenty":-0.751311,"median":-0.451168,"eighty":-0.30245,"marketCap":6850964},{"date":"2025-02-28","current":-0.840366,"twenty":-0.753452,"median":-0.452677,"eighty":-0.30359,"marketCap":7312086},{"date":"2025-03-07","current":-0.710242,"twenty":-0.753452,"median":-0.457022,"eighty":-0.304922,"marketCap":6179866},{"date":"2025-03-14","current":-0.697939,"twenty":-0.751311,"median":-0.45752,"eighty":-0.305517,"marketCap":6072819},{"date":"2025-03-21","current":-0.666099,"twenty":-0.746669,"median":-0.458782,"eighty":-0.306668,"marketCap":5969890},{"date":"2025-03-28","current":-0.654614,"twenty":-0.742758,"median":-0.460599,"eighty":-0.307522,"marketCap":5866961},{"date":"2025-04-04","current":-0.597422,"twenty":-0.741572,"median":-0.462322,"eighty":-0.30825,"marketCap":5354374},{"date":"2025-04-11","current":-0.360284,"twenty":-0.741572,"median":-0.462,"eighty":-0.309143,"marketCap":3229031},{"date":"2025-04-17","current":-0.393753,"twenty":-0.739272,"median":-0.460599,"eighty":-0.309568,"marketCap":3528996},{"date":"2025-04-21","current":-0.359535,"twenty":-0.738173,"median":-0.460563,"eighty":-0.309633,"marketCap":3222326}],"updateTime":1745342938013}}}